MedPath

Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women

Not Applicable
Completed
Conditions
Transgender Women
Interventions
Other: No intervention
Other: Estradiol
Other: Estradiol and Anti-Androgen
Registration Number
NCT06116201
Lead Sponsor
Chulalongkorn University
Brief Summary

Transgender women who transitioned from male to female by hormone therapy demonstrate similar physical fitness and vascular function to males or females.

Detailed Description

This cross-sectional study was to compare physical fitness and vascular function between cisgender men, cisgender women, and transgender women.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Cisgender men group (Body mass index between 18.5-24.9 and NO NCDs).
  2. Cisgender women group (Body mass index between 18.5-24.9, No pregnant, NO NCDs).
  3. Transgender women with orchiectomy (Body mass index between 18.5-24.9, taking estradiol, testosterone level below 10 nmol/L, NO NCDs).
  4. Transgender women without orchiectomy (Body mass index between 18.5-24.9, taking estradiol and anti-androgen, testosterone level below 10 nmol/L, NO NCDs).
Read More
Exclusion Criteria
  • Participants had an injury during testing.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cisgender womenNo interventionCisgender women who lived in normal life were not used medication process for sex transition. They were recruited for measurement of all variables in the study to compare with another group.
Transgender women with orchiectomyEstradiolTransgender women who took medication for sex transition form male to female via estradiol hormone therapy and orchiectomy surgery. They were recruited for measurement of all variables in the study to compare with another group.
Cisgender menNo interventionCisgender men who lived in normal life were not used medication process for sex transition. They were recruited for measurement of all variables in the study to compare with another group.
Transgender women without orchiectomyEstradiol and Anti-AndrogenTransgender women who took medication for sex transition form male to female via estradiol hormone and anti-androgen hormone therapy. They were recruited for measurement of all variables in the study to compare with another group.
Primary Outcome Measures
NameTimeMethod
AgilityBaseline

Agility will be measured by T-test protocol with timing gate device (SpeedLight Timing System, Swiftperformance).

HeightBaseline

Height will be measured with automated body composition machine (ioi 353, Jawon medical).

Bone mineral densityBaseline

Bone mineral density will be measured with dual energy x-ray absorptiometry (Prodigy-Pro, GE healthcaare).

T-score of bone densityBaseline

T-score will be measured with dual energy x-ray absorptiometry (Prodigy-Pro, GE healthcaare). T-score was separated into 3 categories, 1 or higher of T-score that is the healthy bone, -1 to -2.5 of T-score that is osteopenia, and -2.5 or lower that is osteoporosis.

FlexibilityBaseline

Sit and reach test will be measured by sit and reach protocol with sit and reach box (Grandsport).

Heart rateBaseline

Heart rate will be measured with automated blood pressure device (CARESCAPE V100, GE Dinamap).

Blood pressureBaseline

Systolic blood pressure and diastolic blood pressure will be measured with automated blood pressure device (CARESCAPE V100, GE Dinamap). Mean arterial blood pressure was calculated from systolic blood pressure and diastolic blood pressure via mean arterial pressure formula.

Muscular powerBaseline

Muscular power will be measured by vertical jump with force plate detected machine (Ballistic Measurement System \& FT 700 Power Cage, Fitness Technology).

SpeedBaseline

Speed will be measured by sprint test for 40 meters with timing gate device (SpeedLight Timing System, Swiftperformance).

Body weightBaseline

Body weight and height will be measured with automated body composition machine (ioi 353, Jawon medical).

Macro vascular functionBaseline

Macro vascular function will be measured by brachial artery flow-mediated dilatation protocol on brachial artery with ultrasonography equipment (EPIQ 5G, Phillips).

Arterial stiffnessBaseline

Arterial stiffness will be measured with brachial-ankle pulse wave velocity (VP-1000 plus, omrom Healthcare).

Micro vascular functionBaseline

Micro vascular function will be measured by post-occlusive hyperemia protocol of fingertip cutaneous blood flow with laser doppler flowmetry device (PeriFlux system 5000, Perimed).

Muscle massBaseline

Muscle mass will be measured with dual energy x-ray absorptiometry (Prodigy-Pro, GE healthcaare).

Resting metabolic rateBaseline

Energy expenditure will be measured by canopy study protocol with stationary gas analyzer (VMAX, Encore 29 system).

Vascular structureBaseline

Intima-Media Thickness will be measured with ultrasonography equipment on carotid artery (EPIQ 5G, Phillips).

Muscle strength and muscle enduranceBaseline

Muscle strength and muscle endurance will be measured by concentric/concentric protocol with isokinetic machine (Biodex Multi-Joint System-Pro, Biodex).

BalanceBaseline

Balance will be measured by balance error scoring system (BESS) protocol with postural sway detected machine (Biosway, Biodex).

Anaerobic fitnessBaseline

Anaerobic fitness will be measured by Wingate test protocol with ergocycle (Monark 894e).

Fat massBaseline

Fat mass will be measured with dual energy x-ray absorptiometry (Prodigy-Pro, GE healthcaare).

Bone mineral contentBaseline

Bone mineral content will be measured with dual energy x-ray absorptiometry (Prodigy-Pro, GE healthcaare).

Cardiorespiratory fitnessBaseline

Maximal oxygen consumption will be measured by Bruce protocol for treadmill test with stationary gas analyzer (VMAX, Encore 29 system).

Coordination and reaction timeBaseline

Coordination and reaction time will be measured by eye-hand coordination protocol with light reacted device (FITLIGHT Trainer).

Secondary Outcome Measures
NameTimeMethod
Stress levelBaseline

Stress level will be measured by Suanprung Stress Test-20 questionnaire. The scores of questionnaire were 100 points for maximum value and 20 points for minimum value. 4 levels in stress less than 24 points for low stress range, 24-41 points for normal stress range, 42-61 points for high stress range, and more than 61 points for severe stress range.

Quality of life levelBaseline

Quality of life will level will be measured by World Health Organization Quality of Life Brief - Thai questionnaire. The scores of questionnaire were 130 points for maximum value and 26 points for minimum value. 3 levels in quality of life were less than 61 points for below normal range, 61-95 points for normal range, and more than 95 points for above normal range.

Trial Locations

Locations (1)

Faculty of Sports Science, Chulalongkorn University

🇹🇭

Pathum Wan, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath